PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of molvisLink to Publisher's site
 
Mol Vis. 2009; 15: 1098–1106.
Published online Jun 2, 2009.
PMCID: PMC2690955
Leber congenital amaurosis caused by Lebercilin (LCA5) mutation: Retained photoreceptors adjacent to retinal disorganization
Samuel G. Jacobson,corresponding author1 Tomas S. Aleman,1 Artur V. Cideciyan,1 Alexander Sumaroka,1 Sharon B. Schwartz,1 Elizabeth A.M. Windsor,1 Malgorzata Swider,1 Waldo Herrera,1 and Edwin M. Stone2
1Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA
2Howard Hughes Medical Institute and Department of Ophthalmology, University of Iowa Hospitals and Clinics, Iowa City, IA
corresponding authorCorresponding author.
Correspondence to: Samuel G. Jacobson, Scheie Eye Institute, University of Pennsylvania, 51 N. 39th Street, Philadelphia, PA, 19104; Phone: (215) 662-9981; FAX: (215) 662-9388; email: jacobsos/at/mail.med.upenn.edu
Received April 7, 2009; Accepted May 22, 2009.
Purpose
To determine the retinal disease expression in the rare form of Leber congenital amaurosis (LCA) caused by Lebercilin (LCA5) mutation.
Methods
Two young unrelated LCA patients, ages six years (P1) and 25 years (P2) at last visit, both with the same homozygous mutation in the LCA5 gene, were evaluated clinically and with noninvasive studies. En face imaging was performed with near-infrared (NIR) reflectance and autofluorescence (AF); cross-sectional retinal images were obtained with optical coherence tomography (OCT). Dark-adapted thresholds were measured in the older patient; and the transient pupillary light reflex was recorded and quantified in both patients.
Results
Both LCA5 patients had light perception vision only, hyperopia, and nystagmus. P1 showed a prominent central island of retinal pigment epithelium (RPE) surrounded by alternating elliptical-appearing areas of decreased and increased pigmentation. Retinal laminar architecture at and near the fovea was abnormal in both patients. Foveal outer nuclear layer (ONL) was present in P1 and P2 but to different degrees. With increasing eccentricity, there was retinal laminar disorganization. Regions of pericentral and midperipheral retina in P1, but not P2, could retain measurable ONL and less laminopathy. P2 had a small central island of perception with >5 log units of sensitivity loss. Pupillary responsiveness was present in both LCA5 patients; the thresholds were abnormally elevated by ≥5.5 log units.
Conclusions
LCA5 patients had evidence of retained photoreceptors mainly in the central retina. Retinal remodeling was present in pericentral regions in both patients. The NIR reflectance and NIR-AF imaging in the younger patient suggested preserved RPE in retinal regions with retained photoreceptors. Detailed phenotype studies in other LCA5 patients with longitudinal follow-up will help determine the feasibility of future intervention in this rare disease.
Leber congenital amaurosis (LCA) is a molecularly heterogeneous retinal disease with visual impairment from early life [1,2]. Gene identification, proof-of-concept and safety studies in animals, and detailed human studies of photoreceptor layer integrity have led to treatment trials in the molecular form of LCA caused by mutations in RPE65, the gene encoding retinal pigment epithelium-specific protein, 65 kDa [3-10]. For other molecular forms of LCA, progress toward human clinical treatment trials is not as far along. One step that can be taken now, however, is to determine the treatment potential of the human diseases using detailed study of molecularly clarified LCA patients. To date, we have conducted studies with this goal in LCA caused by mutations in CEP290 (Centrosomal protein, 290 kDa), CRB1 (Crumbs homolog-1), CRX (Cone-rod homeobox-containing gene), GUCY2D (Guanylate cyclase 2D, retinal), RDH12 (Retinol dehydrogenase 12), RPE65, RPGRIP1 (Retinitis pigmentosa GTPase regulator-interacting protein), or TULP1 (Tubby-like protein 1) [6,11-19].
The LCA5 locus was initially mapped to chromosome 6p14.1 [20,21] and more recently the gene was determined to encode a protein, lebercilin, involved with photoreceptor ciliary function [22,23]. LCA5 accounts for about 1%–2% of LCA. An animal model for LCA5 that will permit further investigations of disease mechanism is awaited [1]. The literature that identified LCA5 genotypes has included clinical descriptions of the disease. There is consensus that LCA5 mutations lead to an early and severe visual disturbance with nystagmus, abnormal visual acuity, nondetectable electroretinograms, and fundus features of retinal degeneration [21,22,24,25]. Further details of retinal phenotype will be needed to define the potential for any future therapeutic approach to this rare disorder. We used clinical evaluation and retinal imaging modalities to study two LCA patients with the same homozygous LCA5 mutation. Dark-adapted psychophysics and pupillometry were used to assay visual function [26,27].
Participants
Two LCA patients with LCA5 mutations underwent complete eye examinations and studies of retinal phenotype. For comparison with the LCA5 results, we included 30 patients (ages 1–59) who had other forms of LCA or retinal degenerations not considered LCA. Also studied were 34 normal participants (ages 5–58). Informed consent was obtained from all participants. The study procedures followed the Declaration of Helsinki and were approved by the institutional review board of the University of Pennsylvania.
En face imaging with scanning laser ophthalmoscope
Near-infrared (NIR) light was used to perform en face imaging with a confocal scanning laser ophthalmoscope (SLO; HRA2, Heidelberg Engineering GmbH, Heidelberg, Germany) without subjecting the diseased retina to undue light exposure [28]. Reflectivity distribution of retinal and subretinal features was imaged with 820 nm NIR light. Health of the RPE was estimated with NIR-autofluorescence (NIR-AF) using 790 nm excitation light and a long-pass blocking filter that allowed detection of fluorescence emissions of >810 nm [16,28-31]. NIR-AF signal is believed to be dominated by the melanolipofuscin in RPE and melanin in the RPE and choroid [16,28-36]. Disease-related changes in RPE melanin content result in spatial variation of the NIR-AF signal intensity, appearance, or both. Imaging was performed in the high-speed mode; 30°×30° of retina was sampled onto a 768×768 pixel image, and video segments of up to 10 s length were obtained at the rate of 8.8 Hz. Detector sensitivity was set to 95% for NIR-AF. Automatic real-time (ART) averaging feature of the manufacturer’s software was used whenever possible. When ART failed, images were exported from the manufacturer’s software and analyzed as previously described [16,28-31].
Optical coherence tomography
Retinal cross-sections were obtained with optical coherence tomography (OCT). Data were acquired in both patients with Fourier-domain (FD) OCT imaging (RTVue-100; Optovue Inc., Fremont, CA). The principles of the method and our recording and analysis techniques have been published [6,10,14,29,37]. For this work, the line protocol of the FD-OCT system, with greater speed of acquisition, was used to obtain 4.5-mm-long scans composed of 1,019 longitudinal reflectivity profiles (LRPs) acquired in approximately 4 ms. Overlapping, nonaveraged, OCT scans were used to produce a digital montage covering up to 9 mm eccentricity from the fovea along the horizontal meridian. A video fundus image was acquired with each OCT scan. Regions of interest in extramacular retina were examined with single horizontal scans; the location and orientation of the scan relative to retinal features (blood vessels, RPE depigmentation, and optic nerve head) were determined by using the digital images of the fundus.
Postacquisition processing of OCT data was performed with custom programs (MATLAB 6.5, MathWorks, Natick, MA). LRPs that composed the OCT scans were aligned by straightening the major RPE reflection [6,10,14,37]. Two nuclear layers, the outer photoreceptor nuclear layer (ONL) and the inner nuclear layer (INL), were defined in regions of scans showing two parallel stereotypical hyporeflective layers sandwiched between the RPE and vitreoretinal interface [6,14,29]. Inner retinal thickness was defined as the distance between the signal transition at the vitreoretinal interface and the sclerad boundary of the INL or the single hyporeflective layer continuous with the INL [6,29,37]. In normal participants, the signal corresponding to the RPE was assumed to be the most sclerad peak within the multi-peaked scattering signal complex [37], deep in the retina. In abnormal retinas, the presumed RPE peak was sometimes the only signal peak deep in the retina; in other cases, it was apposed by other major peaks. In the latter case, the RPE peak was specified manually by considering the properties of the backscattering signal originating from layers vitread and sclerad to it [38]. Also assessed were the presence of photoreceptor inner segment (IS) and outer segment (OS) signal and outer limiting membrane (OLM) signals vitread to the RPE peak [38].
Pupillometry
The direct transient pupillary light reflex (TPLR) was elicited and recorded as previously published [10,26,39]. In brief, TPLR luminance-response functions were derived from responses to increasing intensities (from −6.6 to 2.3 log scot-cd.s.m−2) of green stimuli with short duration (0.1 s) presented monocularly in the dark-adapted state. The light-stimulated pupil was imaged with an infrared-sensitive video camera (LCL-903HS; Watec America Corp., Las Vegas, NV). Images were digitized by two instruments simultaneously: a digital image processor (RK-706PCI ver. 114 3.55; Iscan, Inc., Burlington, MA) sampled the horizontal pupil diameter at 60 Hz; and a video digitizer (PIXCI SV4 board, ver. 2.1; Epix, Inc., Buffalo Grove, IL) produced a computer file of the video sequence. Records were 5.7 s long, with a 1 s prestimulus baseline. Artifacts resulting from blinks were excluded from the analysis. Manual measurement of digitized video images postacquisition complemented automatic measurements performed during the acquisition. TPLR response amplitude was defined as the difference between the pupil diameter at a fixed time (0.9 s) after the onset of the stimulus and the prestimulus baseline. TPLR response threshold was defined as the stimulus luminance that evoked a 0.3 mm criterion (limit of spontaneous oscillations in pupil diameter), [26] amplitude at 0.9 s.
Two patients were diagnosed clinically with LCA in the first few months of life. Both patients had nystagmus, limited visual responding from about one month of age, and nondetectable electroretinograms. There was no family history of similar visual disorders for either patient and there was no known parental consanguinity. Both patients were of Ashkenazi Jewish ancestry. Molecular screening was performed in the patients for variations in the AIPL1, CEP290, CRB1, CRX, GUCY2D, RDH12, RPE65 and RPGRIP1 genes [2]. There were no plausible disease-causing variations in any of these genes. Further studies revealed a homozygous CAG>TAG nucleotide substitution in the coding sequence of the LCA5 gene, resulting in an amino acid change of Gln279Stop. This LCA5 mutation has previously been reported in one other patient of Ashkenazi Jewish ancestry [22].
Clinical features and en face infrared fundus images
P1, at age 6 years, had light perception vision, hyperopia (+6.50 sphere), nystagmus, and no corneal or lenticular opacities. An en face montage of the ocular fundus of P1 using NIR reflectance imaging showed a distinctly demarcated dark central island surrounded by alternating elliptical regions of lighter and darker appearance (Figure 1A). A schematic of the darker-appearing regions is shown (Figure 1A, inset left). The reflectance pattern in LCA5 P1 was in contrast to the more homogeneous NIR reflectance view from an age-matched normal subject (Figure 1A, inset right). The lighter regions in LCA5 P1 showed greater visibility of the choroid, suggesting depigmentation of RPE. Darker regions likely correspond to more preserved RPE. NIR-AF provided further information on the RPE with the use of melanosome-specific signals from the fundus [31]. High intensity NIR-AF signal originates from the irregular-shaped central island, suggesting a preserved or hyperpigmented RPE at this location (Figure 1B). There was a region of lower intensity NIR-AF in the parafovea, and this likely corresponds to chorioretinal atrophic change. At greater eccentricities, there was an incremental increase in NIR-AF. In the superotemporal and superonasal near midperiphery, there was a distinct boundary of a further increase in NIR-AF signal with a spatially homogeneous appearance, representing more retained and pigmented RPE.
Figure 1
Figure 1
En face near-infrared reflectance and autofluorescence images of the LCA5 patients. A: Near-infrared (NIR) reflectance (REF) image of the left fundus of P1 is shown. Inset to the left is a schematic drawing of the retinal regions corresponding to low (more ...)
LCA5 patient 2 (P2) was followed from age 6 months through age 25 years. Visual acuity loss increased from 7/200 (right eye) and 20/400 (left eye) at age 6 years to light perception in both eyes at age 25. A high hyperopic refractive error was present at all visits (+10.00 sphere); there was nystagmus but no corneal or lenticular opacities. Funduscopic examinations throughout the years noted retina-wide granular-appearing pigmentary disturbances and optic disc drusen in both eyes, a finding previously noted in LCA5 [1]. An en face montage of the ocular fundus of P2 at age 25, using NIR reflectance imaging, showed a light appearance with visibility of the choroid, suggesting depigmentation of RPE (Figure 1C). NIR-AF displayed a choroidal-appearing pattern; specifically there was no evidence of a central region of hyperautofluorescence or peripheral boundary to a relatively increased signal (Figure 1D). The optic disc drusen were evident in the NIR reflectance image (Figure 1C, inset) and they revealed hyperautofluorescence under NIR excitation (Figure 1D, inset). Optic disc drusen are known to show AF under short-wavelength excitation [40], but their NIR-AF signals have not been described.
Between ages 8 and 25 years, P2 was able to perform kinetic perimetry and showed only a central island of perception in each eye of roughly 2–3 degrees in diameter (with a large bright target, V-4e). Static threshold perimetry, using an achromatic target (size V, but 1 log unit brighter than the kinetic perimeter 4e) in the dark-adapted state, was performed in the left eye of P2. This was initially done when the patient was 17 years old and then repeated at 25 years of age. The target was only detected in the central field, and thresholds were elevated by >5.5 log units at both visits [27].
Cross-sectional retinal imaging: preserved photoreceptors adjacent to retinal disorganization
Retinal laminar architecture of LCA5 P1 at age 6 years and P2 at 25 years was examined by high resolution cross-sectional OCT imaging (Figure 2). The central 14 mm scan of retina along the horizontal meridian in a normal subject (Figure 2A, upper) illustrates the foveal depression and the hyporeflective and hyperreflective layers that have been shown to have a predictable relationship to histologically defined layers [14,29,37]. Lamination was also present in the patient scans, but there were abnormalities (Figure 2A, middle and lower). Both patients had a foveal depression; this was identified as the deepest pit on raster scanning. P2 had far less depth to the foveal pit than P1; there was notable epiretinal membrane in this scan and in others (data not shown). Unlike the representative normal scan, both patients also showed some tissue vitread to the foveal ONL. The epifoveal tissue in P1 appeared continuous with parafoveal INL and inner plexiform and retinal ganglion cell layers. Foveal ONL thickness in P1 measured 43 µm, which is reduced to about 48% of normal (normal mean±SD=90±8.6 µm; n=5; ages 5–15 years), suggesting loss of foveal cone cells. Foveal ONL thickness in P2 measured 101 µm, which is within normal limits. Whether this hyporeflectivity measured at the fovea in P2 represents only cone nuclei or is a more complex structure with, for example, Müller cell hypertrophy is uncertain [38]. Eccentric to roughly 1.5 mm nasal and temporal to the fovea, the ONL in both patients is barely discernible. At approximately 7 mm eccentricity into the temporal retina, normal lamination is no longer present, and the patient scans have almost a “bilaminar appearance” with a thick vitread hyperreflective layer and a deep thickened hyporeflective layer. The thick superficial layer likely includes inner plexiform layer and retinal ganglion cell layer, and the deeper layer may be an amalgam of thickened INL with remnant photoreceptor nuclei [16,29]. Retinal thickness and especially inner retinal thickness is remarkably greater in P2 than in P1.
Figure 2
Figure 2
Dysmorphology in the retina of LCA5. A: Cross-sectional OCT images across the horizontal meridian are shown for a normal 6-year-old subject (upper) and LCA5, P1 (middle) and P2 (lower). Layers or structures are labeled as individual or combined laminae. (more ...)
We determined whether the residual foveal ONL in the LCA5 patients was expected to be associated with light perception vision. In vivo histopathology of the LCA5 patients was compared to a group of patients with retinal degeneration and similar foveal ONL thickness, and who had been found, by dark-adapted chromatic perimetry, to be at a stage of disease that had reduced vision to a central island with only abnormal cone function [41] (Figure 2B-D).
The 19 patients with retinal degeneration compared with LCA5 patients were in the general clinical category of retinitis pigmentosa (RP) and showed a range of visual acuities from 20/20 to 20/200. These patients were 21 to 59 years of age with diagnoses that included X-linked RP due to RPGR mutations, Usher syndrome 1B and 2A, and ungenotyped RP. Their ONL profiles were similar to those of the LCA5 patients (Figure 2C). This suggested that the foveal cone cells in the LCA5 patients were not functioning optimally.
Magnified views of the foveal center of P1 and P2 (Figure 2D) demonstrate that the IS/OS signal appears ill-defined in P1 or nearly not discernible in P2. For comparison are similar views of the foveal center for a normal subject and for an RP patient. The RP patient has thinned ONL but more definable IS/OS signal and better foveal function (visual acuity, 20/40). This abnormal signal deep to the foveal cone ONL may indicate structural abnormalities in the cone IS/OS, possibly a consequence of a ciliopathy, with resultant visual dysfunction. At greater eccentricities there was severe ONL reduction. Remnants of ONL observed in the nasal retina of P1 were accompanied by a thickened inner retina (Figure 2E, left P1 panel) suggestive of retinal remodeling. Total photoreceptor layer loss in both patients resulted in a disorganized retinal structure with a bilaminar appearance (Figure 2E, right two panels) with a hyper-thick (P1=148 µm; P2=212 µm) inner retina (normal mean±SD=108±20 µm).
Pupillometric abnormalities in LCA5
TPLR was used to quantify objectively the pupillometric sensitivity to light in these two LCA5 patients with limited vision and nondetectable electroretinograms. For dark-adapted normal eyes, a criterion response (0.3 mm contraction at 0.9 s) of the TPLR is near −5.0 log scot-cd.s.m−2 [10,26]. The amplitude of the normal TPLR response grows as a function of stimulus intensity reaching a saturation value of approximately 2 mm by 2 log scot-cd.s.m−2. Both LCA5 patients showed marked abnormalities in TPLR. Responses for the patients were first detectable with higher intensity stimuli. P1’s response was 0.22 mm at 0.4 log scot-cd.s.m−2; and P2’s response was 0.55 mm at 1.4 log scot-cd.s.m−2. Contraction amplitude to the brighter flash was reduced to 51% of normal mean (1.91±0.40 mm, n=12) in P1 and to 29% of normal mean in P2 (Figure 3A). TPLR thresholds derived from intensity response functions were elevated by 5–6 log units in the LCA5 patients (P1=0.51, and P2=1.08 log scot-cd.s.m−2) compared to normal subjects (mean±2SD=-4.74±0.22 log scot-cd.s.m−2, n=12).
Figure 3
Figure 3
Transient pupillary light reflex (TPLR) abnormalities in LCA5 patients. A: Change in pupil diameter is plotted as a function of time in response to short duration (0.1 s) light stimuli of two different intensities (0.4 and 1.4 log scot-cd.s.m−2 (more ...)
The TPLR threshold abnormalities in LCA5 were similar in order of magnitude to those observed in a group of eleven patients, ages 1–58 years, with different molecular causes of LCA and comparable levels of visual dysfunction (visual acuities of 20/800 or worse). The latter group of LCA patients had TPLR thresholds with mean±2SD of 0.78±2.40 log scot-cd.s.m−2 (Figure 3B).
Clinical features shared by most of the LCA5 patients reported to date include the following: severe visual disturbances and nystagmus from birth, hyperopia, nondetectable electroretinograms, and a spectrum of ophthalmoscopic findings from near normal appearance in infancy to pigmentary retinopathy [20-22,24,25]. Macular atrophy was noted in older members of an LCA5 family in which younger members showed minimal change [21]. Maculopathy has also been observed in early stages of the disease in other LCA5 patients [24]. The studies of photoreceptor and RPE integrity in the LCA5 patients of this study extend the previous reports.
The presence of a foveal depression with apparently retained foveal ONL suggests that central retinal development occurred to some degree in the LCA5 patients [42,43]. However, the foveal architecture was not entirely normal: there were visible laminae vitread to the foveal ONL in P1 and thickening of the fovea in P2, the latter being previously noted in choroideremia [38]. The exact basis of these observations is uncertain but could be due, for example, to incomplete migration of the inner retina toward the periphery during foveal development [42,43], epiretinal membrane distortion of foveal structure, or Müller cell activation, hypertrophy or proliferation in response to photoreceptor cell death [38]. Assuming there are retained foveal cone photoreceptors in LCA5, then the comparison of foveal ONL thickness with other retinal degenerations at similar severity levels by OCT structure suggests that LCA5 visual acuity was far worse than that in the others. This may in part be due to dysfunction from a ciliopathy with disrupted protein transport between inner and outer segments [44]. Deep subfoveal retinal structure in the LCA5 patients, however, was definitely abnormal in the region conventionally attributed to photoreceptor IS, cilia, and OS, suggesting a pathological component. Additional study of the outer retina of LCA5 with ultrahigh resolution OCT would seem valuable [45,46]. The low visual acuity at a young age may result from cone photoreceptor ciliopathy but a component of refractive amblyopia also cannot be ruled out.
A diminished photoreceptor layer was detected at extra-central locations, but regions of no detectable ONL were also present. This indicates that even as early as age 6 years, there is considerable photoreceptor loss. Between loci with detectable ONL were regions that had disorganized lamination. The hallmarks of retinal remodeling were present in these regions: thickened inner retinal layers including inner plexiform and nuclear layers, and reduced to imperceptible outer plexiform and outer nuclear layers [16,29,38,47]. We previously compared such OCT findings in human CEP290-LCA and adRP due to rhodopsin mutations with histopathology of relevant murine models (rd16 mouse and T17M rhodopsin mutant mouse) and the results of these studies support the notion of delaminated remodeled retina in the LCA5 patients [16,29].
The pattern of pigment preservation and loss, as revealed by NIR reflectance and AF in P1, is worthy of comment. If pigmentary losses are assumed to be a sequela of photoreceptor losses, as in many other retinal degenerations [29,48], we speculate that the preserved pigment could be a useful surrogate for photoreceptor preservation. The patterns of alternating elliptical-appearing areas of decreased and increased pigmentation are reminiscent of topographical maps of human photoreceptor density [49]. The preserved central photoreceptors and pigment may be simply due to the high density of cones in this region; the ellipse of increased pigmentation near the vessel arcades may represent relative preservation of pigment and photoreceptors due to the higher density of rod photoreceptors in that region. The decreased pigment between these two regions may be due to the drop of receptor density (combined rod and cone) between foveal cone density peak and rod density peak. A more peripheral ring of increased cone density has been documented and may relate to the increased pigment noted in the LCA5 patient [49].
In the current work, the TPLR proved to be a helpful adjunct measure of vision in these LCA5 patients with severe visual loss. Pupils responded to short-duration, bright light stimuli, optimized to elicit a pupillary reflex mediated by conventional photoreceptors [26] although a contribution from intrinsically light-sensitive ganglion cells cannot be ruled out [50]. The TPLR was abnormal in the patients, as has been described in other groups of LCA patients [10,26,39]. Thresholds were extremely elevated as in other LCA patients with comparable degrees of visual loss.
Once animal models of LCA5 are established and investigated, it will be of strong interest to decide how faithfully they will relate to the noninvasive retinal structural and functional findings in LCA5 patients. The major rod loss at an early age, evident already in the 6-year-old LCA5 patient of this study, should be considered even at the proof-of-concept stage of study in models of LCA5. It may be of value eventually to direct therapy at cones, whether by gene replacement or other methods. Our studies of the CEP290 form of LCA, another ciliopathy with mainly a residual central island of cones and RPE, led to a similar recommendation [16].
Acknowledgments
This study was supported by the Foundation Fighting Blindness, Hope for Vision, Macula Vision Research Foundation, and the Grousbeck Family Foundation.
1. den Hollander AI, Roepman R, Koenekoop RK, Cremers FP. Leber congenital amaurosis: genes, proteins and disease mechanisms. Prog Retin Eye Res. 2008;27:391–419. [PubMed]
2. Stone EM. Leber congenital amaurosis - a model for efficient genetic testing of heterogeneous disorders: LXIV Edward Jackson Memorial Lecture. Am J Ophthalmol. 2007;144:791–811. [PubMed]
3. Acland GM, Aguirre GD, Bennett J, Aleman TS, Cideciyan AV, Bennicelli J, Dejneka NS, Pearce-Kelling SE, Maguire AM, Palczewski K, Hauswirth WW, Jacobson SG. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol Ther. 2005;12:1072–82. [PubMed]
4. Jacobson SG, Acland GM, Aguirre GD, Aleman TS, Schwartz SB, Cideciyan AV, Zeiss CJ, Komaromy AM, Kaushal S, Roman AJ, Windsor EA, Sumaroka A, Pearce-Kelling SE, Conlon TJ, Chiodo VA, Boye SL, Flotte TR, Maguire AM, Bennett J, Hauswirth WW. Safety of recombinant adeno-associated virus type 2–RPE65 vector delivered by ocular subretinal injection. Mol Ther. 2006;13:1074–84. [PubMed]
5. Jacobson SG, Boye SL, Aleman TS, Conlon TJ, Zeiss CJ, Roman AJ, Cideciyan AV, Schwartz SB, Komaromy AM, Doobrajh M, Cheung AY, Sumaroka A, Pearce-Kelling SE, Aguirre GD, Kaushal S, Maguire AM, Flotte TR, Hauswirth WW. Safety in nonhuman primates of ocular AAV2–RPE65, a candidate treatment for blindness in Leber congenital amaurosis. Hum Gene Ther. 2006;17:845–58. [PubMed]
6. Jacobson SG, Aleman TS, Cideciyan AV, Sumaroka A, Schwartz SB, Windsor EA, Traboulsi EI, Heon E, Pittler SJ, Milam AH, Maguire AM, Palczewski K, Stone EM, Bennett J. Identifying photoreceptors in blind eyes caused by RPE65 mutations: prerequisite for human gene therapy success. Proc Natl Acad Sci USA. 2005;102:6177–82. [PubMed]
7. Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, Viswanathan A, Holder GE, Stockman A, Tyler N, Petersen-Jones S, Bhattacharya SS, Thrasher AJ, Fitzke FW, Carter BJ, Rubin GS, Moore AT, Ali RR. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med. 2008;358:2231–9. [PubMed]
8. Maguire AM, Simonelli F, Pierce EA, Pugh EN, Jr, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM, Rossi S, Lyubarsky A, Arruda VR, Konkle B, Stone E, Sun J, Jacobs J, Dell'Osso L, Hertle R, Ma JX, Redmond TM, Zhu X, Hauck B, Zelenaia O, Shindler KS, Maguire MG, Wright JF, Volpe NJ, McDonnell JW, Auricchio A, High KA, Bennett J. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med. 2008;358:2240–8. [PMC free article] [PubMed]
9. Hauswirth WW, Aleman TS, Kaushal S, Cideciyan AV, Schwartz SB, Wang L, Conlon T, Boye SL, Flotte TR, Byrne B, Jacobson SG. Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther. 2008;19:979–90. [PMC free article] [PubMed]
10. Cideciyan AV, Aleman TS, Boye SL, Schwartz SB, Kaushal S, Roman AJ, Pang JJ, Sumaroka A, Windsor EA, Wilson JM, Flotte TR, Fishman GA, Heon E, Stone EM, Byrne BJ, Jacobson SG, Hauswirth WW. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci USA. 2008;105:15112–7. [PubMed]
11. Jacobson SG, Cideciyan AV, Huang Y, Hanna DB, Freund CL, Affatigato LM, Carr RE, Zack DJ, Stone EM, McInnes RR. Retinal degenerations with truncation mutations in the cone-rod homeobox (CRX) gene. Invest Ophthalmol Vis Sci. 1998;39:2417–26. [PubMed]
12. Lewis CA, Batlle IR, Batlle KG, Banerjee P, Cideciyan AV, Huang J, Alemán TS, Huang Y, Ott J, Gilliam TC, Knowles JA, Jacobson SG. Tubby-like protein 1 homozygous splice-site mutation causes early-onset severe retinal degeneration. Invest Ophthalmol Vis Sci. 1999;40:2106–14. [PubMed]
13. Milam AH, Barakat MR, Gupta N, Rose L, Aleman TS, Pianta MJ, Cideciyan AV, Sheffield VC, Stone EM, Jacobson SG. Clinicopathologic effects of mutant GUCY2D in Leber congenital amaurosis. Ophthalmology. 2003;110:549–58. [PubMed]
14. Jacobson SG, Cideciyan AV, Aleman TS, Pianta MJ, Sumaroka A, Schwartz SB, Smilko EE, Milam AH, Sheffield VC, Stone EM. Crumbs homolog 1 (CRB1) mutations result in a thick human retina with abnormal lamination. Hum Mol Genet. 2003;12:1073–8. [PubMed]
15. Jacobson SG, Cideciyan AV, Aleman TS, Sumaroka A, Schwartz SB, Windsor EA, Roman AJ, Heon E, Stone EM, Thompson DA. RDH12 and RPE65, visual cycle genes causing Leber congenital amaurosis, differ in disease expression. Invest Ophthalmol Vis Sci. 2007;48:332–8. [PubMed]
16. Cideciyan AV, Aleman TS, Jacobson SG, Khanna H, Sumaroka A, Aguirre GK, Schwartz SB, Windsor EA, He S, Chang B, Stone EM, Swaroop A. Centrosomal-ciliary gene CEP290/NPHP6 mutations result in blindness with unexpected sparing of photoreceptors and visual brain: implications for therapy of Leber congenital amaurosis. Hum Mutat. 2007;28:1074–83. [PubMed]
17. Jacobson SG, Cideciyan AV, Aleman TS, Sumaroka A, Schwartz SB, Roman AJ, Stone EM. Leber congenital amaurosis caused by an RPGRIP1 mutation shows treatment potential. Ophthalmology. 2007;114:895–8. [PubMed]
18. Jacobson SG, Aleman TS, Cideciyan AV, Heon E, Golczak M, Beltran WA, Sumaroka A, Schwartz SB, Roman AJ, Windsor EA, Wilson JM, Aguirre GD, Stone EM, Palczewski K. Human cone photoreceptor dependence on RPE65 isomerase. Proc Natl Acad Sci USA. 2007;104:15123–8. [PubMed]
19. Jacobson SG, Cideciyan AV, Aleman TS, Sumaroka A, Windsor EA, Schwartz SB, Heon E, Stone EM. Photoreceptor layer topography in children with Leber congenital amaurosis caused by RPE65 mutations. Invest Ophthalmol Vis Sci. 2008;49:4573–7. [PMC free article] [PubMed]
20. Dharmaraj S, Li Y, Robitaille JM, Silva E, Zhu D, Mitchell TN, Maltby LP, Baffoe-Bonnie AB, Maumenee IH. A novel locus for Leber congenital amaurosis maps to chromosome 6q. Am J Hum Genet. 2000;66:319–26. [PubMed]
21. Mohamed MD, Topping NC, Jafri H, Raashed Y, McKibbin MA, Inglehearn CF. Progression of phenotype in Leber's congenital amaurosis with a mutation at the LCA5 locus. Br J Ophthalmol. 2003;87:473–5. [PMC free article] [PubMed]
22. den Hollander AI, Koenekoop RK, Mohamed MD, Arts HH, Boldt K, Towns KV, Sedmak T, Beer M, Nagel-Wolfrum K, McKibbin M, Dharmaraj S, Lopez I, Ivings L, Williams GA, Springell K, Woods CG, Jafri H, Rashid Y, Strom TM, van der Zwaag B, Gosens I, Kersten FF, van Wijk E, Veltman JA, Zonneveld MN, van Beersum SE, Maumenee IH, Wolfrum U, Cheetham ME, Ueffing M, Cremers FP, Inglehearn CF, Roepman R. Mutations in LCA5, encoding the ciliary protein lebercilin, cause Leber congenital amaurosis. Nat Genet. 2007;39:889–95. [PubMed]
23. van Wijk E, Kersten FF, Kartono A, Mans DA, Brandwijk K, Letteboer SJ, Peters TA, Märker T, Yan X, Cremers CW, Cremers FP, Wolfrum U, Roepman R, Kremer H. Usher syndrome and Leber congenital amaurosis are molecularly linked via a novel isoform of the centrosomal ninein-like protein. Hum Mol Genet. 2009;18:51–64. [PMC free article] [PubMed]
24. Gerber S, Hanein S, Perrault I, Delphin N, Aboussair N, Leowski C, Dufier JL, Roche O, Munnich A, Kaplan J, Rozet JM. Mutations in LCA5 are an uncommon cause of Leber congenital amaurosis (LCA) type II. Hum Mutat. 2007;28:1245. [PubMed]
25. Ramprasad VL, Soumittra N, Nancarrow D, Sen P, McKibbin M, Williams GA, Arokiasamy T, Lakshmipathy P, Inglehearn CF, Kumaramanickavel G. Identification of a novel splice-site mutation in the Lebercilin (LCA5) gene causing Leber congenital amaurosis. Mol Vis. 2008;14:481–6. [PMC free article] [PubMed]
26. Aleman TS, Jacobson SG, Chico JD, Scott ML, Cheung AY, Windsor EA, Furushima M, Redmond TM, Bennett J, Palczewski K, Cideciyan AV. Impairment of the transient pupillary light reflex in Rpe65(−/−) mice and humans with Leber congenital amaurosis. Invest Ophthalmol Vis Sci. 2004;45:1259–71. [PubMed]
27. Jacobson SG, Aleman TS, Cideciyan AV, Roman AJ, Sumaroka A, Windsor EA, Schwartz SB, Heon E, Stone EM. Defining the residual vision in leber congenital amaurosis caused by RPE65 mutations. Invest Ophthalmol Vis Sci. 2009;50:2368–75. [PMC free article] [PubMed]
28. Cideciyan AV, Swider M, Aleman TS, Roman MI, Sumaroka A, Schwartz SB, Stone EM, Jacobson SG. Reduced-illuminance autofluorescence imaging in ABCA4-associated retinal degenerations. J Opt Soc Am A Opt Image Sci Vis. 2007;24:1457–67. [PMC free article] [PubMed]
29. Aleman TS, Cideciyan AV, Sumaroka A, Windsor EA, Herrera W, White DA, Kaushal S, Naidu A, Roman AJ, Schwartz SB, Stone EM, Jacobson SG. Retinal laminar architecture in human retinitis pigmentosa caused by Rhodopsin gene mutations. Invest Ophthalmol Vis Sci. 2008;49:1580–90. [PMC free article] [PubMed]
30. Herrera W, Aleman TS, Cideciyan AV, Roman AJ, Banin E, Ben-Yosef T, Gardner LM, Sumaroka A, Windsor EA, Schwartz SB, Stone EM, Liu XZ, Kimberling WJ, Jacobson SG. Retinal disease in Usher syndrome III caused by mutations in the clarin-1 gene. Invest Ophthalmol Vis Sci. 2008;49:2651–60. [PubMed]
31. Gibbs D, Cideciyan AV, Jacobson SG, Williams D. Retinal pigment epithelium defects in humans and mice with mutations in MYO7A: imaging melanosome-specific autofluorescence. Invest Ophthalmol Vis Sci. 2009 [PMC free article] [PubMed]
32. Weinberger AW, Lappas A, Kirschkamp T, Mazinani BA, Huth JK, Mohammadi B, Walter P. Fundus near infrared fluorescence correlates with fundus near infrared reflectance. Invest Ophthalmol Vis Sci. 2006;47:3098–108. [PubMed]
33. Keilhauer CN, Delori FC. Near-infrared autofluorescence imaging of the fundus: visualization of ocular melanin. Invest Ophthalmol Vis Sci. 2006;47:3556–64. [PubMed]
34. Kellner U, Kellner S, Weinitz S. Chloroquine retinopathy: lipofuscin- and melanin-related fundus autofluorescence, optical coherence tomography and multifocal electroretinography. Doc Ophthalmol. 2008;116:119–27. [PubMed]
35. Kellner U, Kellner S, Weber BH, Fiebig B, Weinitz S, Ruether K. Lipofuscin- and melanin-related fundus autofluorescence visualize different retinal pigment epithelial alterations in patients with retinitis pigmentosa. Eye. 2008 [PubMed]
36. Theelen T, Boon CJ, Klevering BJ, Hoyng CB. [Fundus autofluorescence in patients with inherited retinal diseases: patterns of fluorescence at two different wavelengths]. German. Ophthalmologe. 2008;105:1013–22. [PubMed]
37. Huang Y, Cideciyan AV, Papastergiou GI, Banin E, Semple-Rowland SL, Milam AH, Jacobson SG. Relation of optical coherence tomography to microanatomy in normal and rd chickens. Invest Ophthalmol Vis Sci. 1998;39:2405–16. [PubMed]
38. Jacobson SG, Cideciyan AV, Sumaroka A, Aleman TS, Schwartz SB, Windsor EA, Roman AJ, Stone EM, MacDonald IM. Remodeling of the human retina in choroideremia: rab escort protein 1 (REP-1) mutations. Invest Ophthalmol Vis Sci. 2006;47:4113–20. [PubMed]
39. Aguirre GK, Komáromy AM, Cideciyan AV, Brainard DH, Aleman TS, Roman AJ, Avants BB, Gee JC, Korczykowski M, Hauswirth WW, Acland GM, Aguirre GD, Jacobson SG. Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation. PLoS Med. 2007;4:e230. [PMC free article] [PubMed]
40. Mustonen E, Nieminen H. Optic disc drusen–a photographic study. I. Autofluorescence pictures and fluorescein angiography. Acta Ophthalmol (Copenh) 1982;60:849–58. [PubMed]
41. Roman AJ, Schwartz SB, Aleman TS, Cideciyan AV, Chico JD, Windsor EA, Gardner LM, Ying GS, Smilko EE, Maguire MG, Jacobson SG. Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures. Exp Eye Res. 2005;80:259–72. [PubMed]
42. Provis JM, Diaz CM, Dreher B. Ontogeny of the primate fovea: a central issue in retinal development. Prog Neurobiol. 1998;54:549–80. [PubMed]
43. Yuodelis C, Hendrickson A. A qualitative and quantitative analysis of the human fovea during development. Vision Res. 1986;26:847–55. [PubMed]
44. Besharse JC, Baker SA, Luby-Phelps K, Pazour GJ. Photoreceptor intersegmental transport and retinal degeneration: a conserved pathway common to motile and sensory cilia. Adv Exp Med Biol. 2003;533:157–64. [PubMed]
45. Ruggeri M, Wehbe H, Jiao S, Gregori G, Jockovich ME, Hackam A, Duan Y, Puliafito CA. In vivo three-dimensional high-resolution imaging of rodent retina with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2007;48:1808–14. [PubMed]
46. Srinivasan VJ, Chen Y, Duker JS, Fujimoto JG. In vivo functional imaging of intrinsic scattering changes in the human retina with high-speed ultrahigh resolution OCT. Opt Express. 2009;17:3861–77. [PMC free article] [PubMed]
47. Aleman TS, Cideciyan AV, Sumaroka A, Schwartz SB, Roman AJ, Windsor EA, Steinberg JD, Branham K, Othman M, Swaroop A, Jacobson SG. Inner retinal abnormalities in X-linked retinitis pigmentosa with RPGR mutations. Invest Ophthalmol Vis Sci. 2007;48:4759–65. [PMC free article] [PubMed]
48. Milam AH, Li ZY, Fariss RN. Histopathology of the human retina in retinitis pigmentosa. Prog Retin Eye Res. 1998;17:175–205. [PubMed]
49. Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. Human photoreceptor topography. J Comp Neurol. 1990;292:497–523. [PubMed]
50. Guler AD, Ecker JL, Lall GS, Haq S, Altimus CM, Liao HW, Barnard AR, Cahill H, Badea TC, Zhao H, Hawkins MW, Berson DM, Lucas RJ, Yau KW, Hattar S. Melanopsin cells are the principal conduits for rod-cone input to non-image-forming vision. Nature. 2008;453:102–5. [PMC free article] [PubMed]
Articles from Molecular Vision are provided here courtesy of
Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R. China